Loaded Leukosomes: A Smart Bomb to Halt Vascular Inflammation

Gábor Csányi^{1

2}, Rudolf Lucas^{1

2

3}, Brian H Annex^{2

3}

Affiliations

¹ From the Pharmacology and Toxicology (G.C., R.L.), Medical College of Georgia at Augusta University.
² Vascular Biology Center (G.C., R.L., B.H.A.), Medical College of Georgia at Augusta University.
³ Department of Medicine (R.L., B.H.A.), Medical College of Georgia at Augusta University.

Editorial

Gábor Csányi et al. Circ Res. 2020.

. 2020 Jan 3;126(1):38-40.

doi: 10.1161/CIRCRESAHA.119.316249. Epub 2020 Jan 2.

Gábor Csányi^{1

2}, Rudolf Lucas^{1

2

3}, Brian H Annex^{2

3}

¹ From the Pharmacology and Toxicology (G.C., R.L.), Medical College of Georgia at Augusta University.
² Vascular Biology Center (G.C., R.L., B.H.A.), Medical College of Georgia at Augusta University.
³ Department of Medicine (R.L., B.H.A.), Medical College of Georgia at Augusta University.

No abstract available

Keywords: Editorials; atherosclerosis; cytokines; inflammation; nanoparticles.

Comment on

Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.
Boada C, Zinger A, Tsao C, Zhao P, Martinez JO, Hartman K, Naoi T, Sukhoveshin R, Sushnitha M, Molinaro R, Trachtenberg B, Cooke JP, Tasciotti E. Boada C, et al. Circ Res. 2020 Jan 3;126(1):25-37. doi: 10.1161/CIRCRESAHA.119.315185. Epub 2019 Oct 24. Circ Res. 2020. PMID: 31647755

1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56–e528. doi: 10.1161/CIR.0000000000000659 - DOI - PubMed
1. Boada C, Zinger A, Tsao C, Zhao P, Martinez JO, Hartman K, Naoi T, Sukhovershin R, Sushnitha M, Molinaro R, et al. Rapamycin-loaded biomimetic nanoparticles reverse vascular inflammation. Circ Res. 2020;126:25–37. doi: 10.1161/CIRCRESAHA.119.315185 - DOI - PubMed
1. Lin CH, Chao CT, Wu MY, Lo WC, Lin TC, Wu MS. Use of mammalian target of rapamycin inhibitors in patient with autosomal dominant polycystic kidney disease: an updated meta-analysis. Int Urol Nephrol. 2019;51:2015–2025. doi: 10.1007/s11255-019-02292-1 - DOI - PubMed
1. Brattström C, Wilczek H, Tydén G, Böttiger Y, Säwe J, Groth CG. Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin). Transplantation. 1998;65:1272–1274. doi: 10.1097/00007890-199805150-00023 - DOI - PubMed
1. Myasoedova VA, Chistiakov DA, Grechko AV, Orekhov AN. Matrix metalloproteinases in pro-atherosclerotic arterial remodeling. J Mol Cell Cardiol. 2018;123:159–167. doi: 10.1016/j.yjmcc.2018.08.026 - DOI - PubMed